These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24277655)

  • 21. Withdrawal of statins increases event rates in patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Laufs U; Snapinn S; Böhm M; White HD;
    Circulation; 2002 Mar; 105(12):1446-52. PubMed ID: 11914253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prior statin therapy is associated with a decreased rate of severe sepsis.
    Almog Y; Shefer A; Novack V; Maimon N; Barski L; Eizinger M; Friger M; Zeller L; Danon A
    Circulation; 2004 Aug; 110(7):880-5. PubMed ID: 15289367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins for infection and sepsis: a systematic review of the clinical evidence.
    Falagas ME; Makris GC; Matthaiou DK; Rafailidis PI
    J Antimicrob Chemother; 2008 Apr; 61(4):774-85. PubMed ID: 18263570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of statin therapy in patients with acute respiratory distress syndrome/acute lung injury: a systematic review and meta-analysis.
    Feng Y
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3190-3198. PubMed ID: 29863265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
    Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
    Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of discontinuing or continuing ongoing statin therapy in severe sepsis and septic shock: a retrospective cohort study.
    Mekontso Dessap A; Ouanes I; Rana N; Borghi B; Bazin C; Katsahian S; Hulin A; Brun-Buisson C
    Crit Care; 2011 Jul; 15(4):R171. PubMed ID: 21767409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Sepsis and Mortality With Prior Exposure of HMG-COA Reductase Inhibitors in a Surgical Intensive Care Population.
    Schurr JW; Wu W; Smith-Hannah A; Smith CJ; Barrera R
    Shock; 2016 Jan; 45(1):10-5. PubMed ID: 26674450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile.
    Napoli C; Sica V
    Curr Pharm Des; 2004; 10(4):425-32. PubMed ID: 14965203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
    Zechmeister C; Hurren J; McNorton K
    Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
    BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of statins on mortality in septic patients: a meta-analysis of randomized controlled trials.
    Pasin L; Landoni G; Castro ML; Cabrini L; Belletti A; Feltracco P; Finco G; Carozzo A; Chiesa R; Zangrillo A
    PLoS One; 2013; 8(12):e82775. PubMed ID: 24391721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
    McCarty MF
    Med Hypotheses; 2002 Sep; 59(3):268-79. PubMed ID: 12208152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.
    O'Neal HR; Koyama T; Koehler EA; Siew E; Curtis BR; Fremont RD; May AK; Bernard GR; Ware LB
    Crit Care Med; 2011 Jun; 39(6):1343-50. PubMed ID: 21336116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in mortality associated with statin therapy in patients with severe sepsis.
    Dobesh PP; Klepser DG; McGuire TR; Morgan CW; Olsen KM
    Pharmacotherapy; 2009 Jun; 29(6):621-30. PubMed ID: 19476415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early statin initiation and outcomes in patients with acute coronary syndromes.
    Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
    JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins in sepsis.
    Dobesh PP; Swahn SM; Peterson EJ; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):38-49. PubMed ID: 21507792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.